Last updated on March 2017

Clinical Trial Evaluating ITI-007 as an Adjunctive Therapy to Lithium or Valproate for the Treatment of Bipolar Depression


Brief description of study

The study will evaluate the efficacy and safety of ITI-007 adjunctive to lithium or valproate in a randomized, double-blind, parallel-group, placebo-controlled, multi-center study in patients diagnosed with Bipolar I or Bipolar II disorder having a major depressive episode.

Clinical Study Identifier: NCT02600507

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Kimberly Vanover, Ph.D.

Clinical Site
Little Rock, AR United States
  Connect »

Kimberly Vanover, Ph.D.

Clinical Site
Rogers, AR United States
  Connect »

Kimberly Vanover, Ph.D.

Clinical Site
Cerritos, CA United States
  Connect »

Kimberly Vanover, Ph.D.

Clinical Site
Culver City, CA United States
  Connect »

Kimberly Vanover, Ph.D.

Clinical Site
Garden Grove, CA United States
  Connect »

Kimberly Vanover, Ph.D.

Clinical Site
National City, CA United States
  Connect »

Kimberly Vanover, Ph.D.

Clinical Site
Oceanside, CA United States
  Connect »

Kimberly Vanover, Ph.D.

Clinical Site
Pico Rivera, CA United States
  Connect »

Kimberly Vanover, Ph.D.

Clinical Site
Riverside, CA United States
  Connect »

Kimberly Vanover, Ph.D.

Clinical Site
San Diego, CA United States
  Connect »

Kimberly Vanover, Ph.D.

Clinical Site
San Marcos, CA United States
  Connect »

Kimberly Vanover, Ph.D.

Clinical Site
Colorado Springs, CO United States
  Connect »

Kimberly Vanover, Ph.D.

Clinical Site
Bradenton, FL United States
  Connect »

Kimberly Vanover, Ph.D.

Clinical Site
Lauderhill, FL United States
  Connect »

Kimberly Vanover, Ph.D.

Clinical Site
North Miami, FL United States
  Connect »

Kimberly Vanover, Ph.D.

Clinical Site
Orlando, FL United States
  Connect »

Kimberly Vanover, Ph.D.

Clinical Site
Atlanta, GA United States
  Connect »

Kimberly Vanover, Ph.D.

Clinical Site
Chicago, IL United States
  Connect »

Kimberly Vanover, Ph.D.

Clinical Site
Hoffman Estates, IL United States
  Connect »

Kimberly Vanover, Ph.D.

Clinical Site
Lake Charles, LA United States
  Connect »

Kimberly Vanover, Ph.D.

Clinical Site
Boston, MA United States
  Connect »

Kimberly Vanover, Ph.D.

Clinical Site
Saint Louis, MO United States
  Connect »

Kimberly Vanover, Ph.D.

Clinical Site
Las Vegas, NV United States
  Connect »

Kimberly Vanover, Ph.D.

Clinical Site
Berlin, NJ United States
  Connect »

Kimberly Vanover, Ph.D.

Clinical Site
Cherry Hill, NJ United States
  Connect »

Kimberly Vanover, Ph.D.

Clinical Site
Marlton, NJ United States
  Connect »

Kimberly Vanover, Ph.D.

Clinical Site
Brooklyn, NY United States
  Connect »

Kimberly Vanover, Ph.D.

Clinical Site
Cedarhurst, NY United States
  Connect »

Kimberly Vanover, Ph.D.

Clinical Site
Rochester, NY United States
  Connect »

Kimberly Vanover, Ph.D.

Clinical Site
Staten Island, NY United States
  Connect »

Kimberly Vanover, Ph.D.

Clinical Site
Cleveland, OH United States
  Connect »

Kimberly Vanover, Ph.D.

Clinical Site
Dayton, OH United States
  Connect »

Kimberly Vanover, Ph.D.

Clinical Site
Oklahoma City, OK United States
  Connect »

Kimberly Vanover, Ph.D.

Clinical Site
Portland, OR United States
  Connect »

Kimberly Vanover, Ph.D.

Clinical Site
Norristown, PA United States
  Connect »

Kimberly Vanover, Ph.D.

Clinical Site
Philadelphia, PA United States
  Connect »

Kimberly Vanover, Ph.D.

Clinical Site
Austin, TX United States
  Connect »

Kimberly Vanover, Ph.D.

Clinical Site
Dallas, TX United States
  Connect »

Kimberly Vanover, Ph.D.

Clinical Site
Houston, TX United States
  Connect »